The Corporate Transparency Act (CTA) went into effect on January 1, 2024, and will impact millions of U.S. businesses by
Continue Reading The Corporate Transparency Act: What you Need to Know to Comply with the New RequirementsAydin H. Harston
Aydin Harston combines his love for science and technology with legal expertise to advocate for his clients in all matters necessary to grow, protect, and defend their businesses. With a Ph.D. in biochemistry and numerous scientific and legal publications, Aydin seeks to produce creative and effective approaches to achieve his clients' goals as efficiently as possible.
USPTO Fees Are Rising Drastically in 2025: What to Do Now to Save Thousands of Dollars
Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO).
Continue Reading USPTO Fees Are Rising Drastically in 2025: What to Do Now to Save Thousands of DollarsClient Spotlight: BASE Air Management
BASE Air is a company at the leading edge of safety in the heavy vehicle industry. Founded in 2005 by…
Continue Reading Client Spotlight: BASE Air ManagementGene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell DiseaseGene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare DiseasesKeeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act
Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with…
Continue Reading Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole ActThe Evolving Gene Editing Landscape: From Research Tool to Market
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and…
Continue Reading The Evolving Gene Editing Landscape: From Research Tool to MarketAmgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio
On July 27, 2021, Amgen announced that it will acquire Bay area-based Teneobio, a privately held, clinical stage biotechnology…
Continue Reading Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio
Pitfalls of Attorney-Client Privilege and Tips for Corporate Officers and Employees
Elizabeth Holmes, former CEO of the now-defunct blood-testing technology company Theranos, recently learned a harsh lesson on the complexities and…
Continue Reading Pitfalls of Attorney-Client Privilege and Tips for Corporate Officers and Employees